Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 1870675, 10 pages
http://dx.doi.org/10.1155/2016/1870675
Review Article

The Role of the Transcription Factor Foxo3 in Hearing Maintenance: Informed Speculation on a New Player in the Cochlea

Department of Neuroscience, University of Rochester School of Medicine and Dentistry, Box 603, 601 Elmwood Avenue, Rochester, NY 14642, USA

Received 31 May 2016; Revised 31 August 2016; Accepted 19 September 2016

Academic Editor: Kenneth W. Altman

Copyright © 2016 Patricia M. White. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. NIDCD, Quick Statistics on Hearing Loss Bethesda, MD: National Institute of Health, 2010, http://www.nidcd.nih.gov/health/statistics/Pages/quick.aspx
  2. R. Hinchcliffe, “Occupational deafness,” Proceedings of the Royal Society of Medicine, vol. 60, pp. 1111–1117, 1967. View at Google Scholar
  3. S. D. Stephens, “A case of gentamicin accentuated hearing loss,” The Journal of Laryngology & Otology, vol. 82, no. 9, pp. 803–808, 1968. View at Publisher · View at Google Scholar
  4. E. Fransen, S. Bonneux, J. J. Corneveaux et al., “Genome-wide association analysis demonstrates the highly polygenic character of age-related hearing impairment,” European Journal of Human Genetics, vol. 23, no. 1, pp. 110–115, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Van Camp and R. Smith, Hereditary Hearing Loss Homepage, University of Iowa, Iowa City, Iowa, USA, 2015, http://hereditaryhearingloss.org/.
  6. R. A. Friedman, L. Van Laer, M. J. Huentelman et al., “GRM7 variants confer susceptibility to age-related hearing impairment,” Human Molecular Genetics, vol. 18, no. 4, pp. 785–796, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Van Laer, J. R. Huyghe, S. Hannula et al., “A genome-wide association study for age-related hearing impairment in the Saami,” European Journal of Human Genetics, vol. 18, no. 6, pp. 685–693, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Girotto, N. Pirastu, R. Sorice et al., “Hearing function and thresholds: a genome-wide association study in European isolated populations identifies new loci and pathways,” Journal of Medical Genetics, vol. 48, no. 6, pp. 369–374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. L. S. Nolan, H. Maier, I. Hermans-Borgmeyer et al., “Estrogen-related receptor gamma and hearing function: evidence of a role in humans and mice,” Neurobiology of Aging, vol. 34, no. 8, pp. 2077.e1–2077.e9, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. D. J. Lim, “Ultrastructural cochlear changes following acoustic hyperstimulation and ototoxicity,” Annals of Otology, Rhinology & Laryngology, vol. 85, no. 6, part 1, pp. 740–751, 1976. View at Google Scholar
  11. H. F. Schuknecht and M. R. Gacek, “Cochlear pathology in presbycusis,” Annals of Otology, Rhinology & Laryngology, vol. 102, no. 1, part 2, pp. 1–16, 1993. View at Publisher · View at Google Scholar
  12. S. G. Kujawa and M. C. Liberman, “Adding insult to injury: cochlear nerve degeneration after ‘temporary’ noise-induced hearing loss,” Journal of Neuroscience, vol. 29, no. 45, pp. 14077–14085, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. H. W. Lin, A. C. Furman, S. G. Kujawa, and M. C. Liberman, “Primary neural degeneration in the Guinea pig cochlea after reversible noise-induced threshold shift,” Journal of the Association for Research in Otolaryngology, vol. 12, no. 5, pp. 605–616, 2011. View at Publisher · View at Google Scholar
  14. S. J. Crowe, S. R. Guild, and L. M. Polvogt, “Observations on the pathology of high-tone deafness,” Bulletin of the Johns Hopkins Hospital, vol. 54, no. 5, p. 315, 1934. View at Google Scholar
  15. R. Pujol and J.-L. Puel, “Excitotoxicity, synaptic repair, and functional recovery in the mammalian cochlea: a review of recent findings,” Annals of the New York Academy of Sciences, vol. 884, pp. 249–254, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. R. W. Biagi, “Deafness from dihydrostreptomycin,” The British Medical Journal, vol. 2, no. 4732, pp. 651–652, 1951. View at Publisher · View at Google Scholar
  17. L. G. Johnsson, J. E. Hawkins Jr., T. C. Kingsley, F. O. Black, and G. J. Matz, “Aminoglycoside-induced cochlear pathology in man,” Acta Oto-Laryngologica, Supplement, vol. 383, pp. 1–19, 1981. View at Google Scholar · View at Scopus
  18. W. C. Stebbins, J. E. Hawkins Jr., L.-G. Johnsson, and D. B. Moody, “Hearing thresholds with outer and inner hair cell loss,” American Journal of Otolaryngology—Head and Neck Medicine and Surgery, vol. 1, no. 1, pp. 15–27, 1979. View at Publisher · View at Google Scholar · View at Scopus
  19. A. C. Suryadevara, B. A. Schulte, R. A. Schmiedt, and N. B. Slepecky, “Auditory nerve fibers in young and quiet-aged gerbils: morphometric correlations with endocochlear potential,” Hearing Research, vol. 161, no. 1-2, pp. 45–53, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Lang, B. A. Schulte, and R. A. Schmiedt, “Effects of chronic furosemide treatment and age on cell division in the adult gerbil inner ear,” Journal of the Association for Research in Otolaryngology, vol. 4, no. 2, pp. 164–175, 2003. View at Publisher · View at Google Scholar
  21. R. A. Schmiedt, H. Lang, H.-O. Okamura, and B. A. Schulte, “Effects of furosemide applied chronically to the round window: a model of metabolic presbyacusis,” The Journal of Neuroscience, vol. 22, no. 21, pp. 9643–9650, 2002. View at Google Scholar · View at Scopus
  22. E. G. Nelson and R. Hinojosa, “Presbycusis: a human temporal bone study of individuals with downward sloping audiometric patterns of hearing loss and review of the literature,” Laryngoscope, vol. 116, supplement 112, no. 9, pp. 1–12, 2006. View at Publisher · View at Google Scholar
  23. J. Otte, H. F. Schunknecht, and A. G. Kerr, “Ganglion cell populations in normal and pathological human cochleae. Implications for cochlear implantation,” Laryngoscope, vol. 88, no. 8, pp. 1231–1246, 1978. View at Publisher · View at Google Scholar
  24. F. Suga and J. R. Lindsay, “Histopathological observations of presbycusis,” Annals of Otology, Rhinology & Laryngology, vol. 85, no. 2, part 1, pp. 169–184, 1976. View at Google Scholar
  25. H. G. Rizk and F. H. Linthicum Jr., “Histopathologic categorization of presbycusis,” Otology & Neurotology, vol. 33, no. 3, pp. e23–e24, 2012. View at Publisher · View at Google Scholar
  26. F. H. Linthicum Jr. and J. N. Fayad, “Spiral ganglion cell loss is unrelated to segmental cochlear sensory system degeneration in humans,” Otology & Neurotology, vol. 30, no. 3, pp. 418–422, 2009. View at Publisher · View at Google Scholar
  27. E. G. Nelson and R. Hinojosa, “Presbycusis: a human temporal bone study of individuals with flat audiometric patterns of hearing loss using a new method to quantify stria vascularis volume,” Laryngoscope, vol. 113, no. 10, pp. 1672–1686, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. G. A. Gates, D. Mills, B.-H. Nam, R. D'Agostino, and E. W. Rubel, “Effects of age on the distortion product otoacoustic emission growth functions,” Hearing Research, vol. 163, no. 1-2, pp. 53–60, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. R. A. Schmiedt, The Physiology of Cochlear Presbycusis. The Aging Auditory System, Springer Science, Berlin, Germany, 2010.
  30. J. R. Engle, S. Tinling, G. H. Recanzone, and J. Snyder, “Age-related hearing loss in rhesus monkeys is correlated with cochlear histopathologies,” PLoS ONE, vol. 8, no. 2, article e55092, 2013. View at Publisher · View at Google Scholar
  31. P. D. Allen and D. A. Eddins, “Presbycusis phenotypes form a heterogeneous continuum when ordered by degree and configuration of hearing loss,” Hearing Research, vol. 264, no. 1-2, pp. 10–20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Gilels, S. T. Paquette, J. Zhang, I. Rahman, and P. M. White, “Mutation of foxo3 causes adult onset auditory neuropathy and alters cochlear synapse architecture in mice,” Journal of Neuroscience, vol. 33, no. 47, pp. 18409–18424, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Chen and J. Tang, “The role of mitochondria in age-related hearing loss,” Biogerontology, vol. 15, no. 1, pp. 13–19, 2014. View at Publisher · View at Google Scholar
  34. J. Hagenbuchner and M. J. Ausserlechner, “Mitochondria and FOXO3: breath or die,” Frontiers in Physiology, vol. 4, article 147, 2013. View at Publisher · View at Google Scholar
  35. I. Chaves, G. T. J. van der Horst, R. Schellevis et al., “Insulin-FOXO3 signaling modulates circadian rhythms via regulation of clock transcription,” Current Biology, vol. 24, no. 11, pp. 1248–1255, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Kenyon, J. Chang, E. Gensch, A. Rudner, and R. Tabtiang, “A C. elegans mutant that lives twice as long as wild type,” Nature, vol. 366, no. 6454, pp. 461–464, 1993. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Martins, G. J. Lithgow, and W. Link, “Long live FOXO: unraveling the role of FOXO proteins in aging and longevity,” Aging Cell, vol. 15, no. 2, pp. 196–207, 2015. View at Publisher · View at Google Scholar
  38. F. Flachsbart, A. Caliebe, R. Kleindorp et al., “Association of FOXO3A variation with human longevity confirmed in German centenarians,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 8, pp. 2700–2705, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. C. V. Anselmi, A. Malovini, R. Roncarati et al., “Association of the FOXO3A locus with extreme longevity in a Southern Italian centenarian study,” Rejuvenation Research, vol. 12, no. 2, pp. 95–103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Pawlikowska, D. Hu, S. Huntsman et al., “Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity,” Aging Cell, vol. 8, no. 4, pp. 460–472, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. B. J. Willcox, T. A. Donlon, Q. He et al., “FOXO3A genotype is strongly associated with human longevity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 37, pp. 13987–13992, 2008. View at Publisher · View at Google Scholar
  42. M. Soerensen, S. Dato, K. Christensen et al., “Replication of an association of variation in the FOXO3A gene with human longevity using both case-control and longitudinal data,” Aging Cell, vol. 9, no. 6, pp. 1010–1017, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. J. M. Bao, X. L. Song, Y. Q. Hong et al., “Association between FOXO3A gene polymorphisms and human longevity: a meta-analysis,” Asian Journal of Andrology, vol. 16, no. 3, pp. 446–452, 2014. View at Publisher · View at Google Scholar
  44. K. Banasik, R. Ribel-Madsen, A. P. Gjesing et al., “The FOXO3A rs2802292 G-allele associates with improved peripheral and hepatic insulin sensitivity and increased skeletal muscle-FOXO3A mRNA expression in twins,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 1, pp. E119–E124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Brunet, A. Bonni, M. J. Zigmond et al., “Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor,” Cell, vol. 96, no. 6, pp. 857–868, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. L. M. Neri, P. Borgatti, S. Capitani, and A. M. Martelli, “The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, vol. 1584, no. 2-3, pp. 73–80, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Ogg, S. Paradis, S. Gottlieb et al., “The fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans,” Nature, vol. 389, no. 6654, pp. 994–999, 1997. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Weisová, D. Dávila, L. P. Tuffy, M. W. Ward, C. G. Concannon, and J. H. M. Prehn, “Role of 5′-adenosine monophosphate-activated protein kinase in cell survival and death responses in neurons,” Antioxidants and Redox Signaling, vol. 14, no. 10, pp. 1863–1876, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. E. L. Greer, D. Dowlatshahi, M. R. Banko et al., “An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans,” Current Biology, vol. 17, no. 19, pp. 1646–1656, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. E. L. Greer, P. R. Oskoui, M. R. Banko et al., “The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor,” The Journal of Biological Chemistry, vol. 282, no. 41, pp. 30107–30119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. Z. Li, J. Zhao, I. Tikhanovich et al., “Serine 574 phosphorylation alters transcriptional programming of FOXO3 by selectively enhancing apoptotic gene expression,” Cell Death and Differentiation, vol. 23, no. 4, pp. 583–595, 2016. View at Publisher · View at Google Scholar
  52. F. Wang, C. B. Marshall, G.-Y. Li, K. Yamamoto, T. W. Mak, and M. Ikura, “Synergistic interplay between promoter recognition and CBP/p300 coactivator recruitment by FOXO3a,” ACS Chemical Biology, vol. 4, no. 12, pp. 1017–1027, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. R. A. Gottlieb and D. Bernstein, “Mitochondrial remodeling: rearranging, recycling, and reprogramming,” Cell Calcium, vol. 60, no. 2, pp. 88–101, 2016. View at Publisher · View at Google Scholar
  54. K. Itoh, K. Nakamura, M. Iijima, and H. Sesaki, “Mitochondrial dynamics in neurodegeneration,” Trends in Cell Biology, vol. 23, no. 2, pp. 64–71, 2013. View at Publisher · View at Google Scholar
  55. Y. Olmos, I. Valle, S. Borniquel et al., “Mutual dependence of Foxo3a and PGC-1α in the induction of oxidative stress genes,” The Journal of Biological Chemistry, vol. 284, no. 21, pp. 14476–14484, 2009. View at Publisher · View at Google Scholar
  56. Z. Wu, P. Puigserver, U. Andersson et al., “Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1,” Cell, vol. 98, no. 1, pp. 115–124, 1999. View at Publisher · View at Google Scholar · View at Scopus
  57. G. J. P. L. Kops, T. B. Dansen, P. E. Polderman et al., “Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress,” Nature, vol. 419, no. 6904, pp. 316–321, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. W. Qin, V. Haroutunian, P. Katsel et al., “PGC-1α expression decreases in the alzheimer disease brain as a function of dementia,” Archives of Neurology, vol. 66, no. 3, pp. 352–361, 2009. View at Publisher · View at Google Scholar
  59. W. Qin, W. Zhao, L. Ho et al., “Regulation of forkhead transcription factor FoxO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration,” Annals of the New York Academy of Sciences, vol. 1147, pp. 335–347, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Sajan, B. Hansen, R. Ivey III et al., “Brain insulin signaling is increased in insulin-resistant states and decreases in FOXOs and PGC-1α and increases in Aβ1-40/42 and phospho-tau may abet alzheimer development,” Diabetes, vol. 65, no. 7, pp. 1892–1903, 2016. View at Publisher · View at Google Scholar
  61. C. Kang and L. L. Ji, “PGC-1α overexpression via local transfection attenuates mitophagy pathway in muscle disuse atrophy,” Free Radical Biology and Medicine, vol. 93, pp. 32–40, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. A. R. Konopka, M. D. Douglass, L. A. Kaminsky et al., “Molecular adaptations to aerobic exercise training in skeletal muscle of older women,” The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, vol. 65, no. 11, pp. 1201–1207, 2010. View at Publisher · View at Google Scholar
  63. L. Sun, W.-J. Zang, H. Wang et al., “Acetylcholine promotes ROS detoxification against hypoxia/reoxygenation-induced oxidative stress through FoxO3a/PGC-1α dependent superoxide dismutase,” Cellular Physiology and Biochemistry, vol. 34, no. 5, pp. 1614–1625, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. D. E. Forman, K. M. Daniels, L. P. Cahalin et al., “Analysis of skeletal muscle gene expression patterns and the impact of functional capacity in patients with systolic heart failure,” Journal of Cardiac Failure, vol. 20, no. 6, pp. 422–430, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. X. Zhao, F. Petursson, B. Viollet, M. Lotz, R. Terkeltaub, and R. Liu-Bryan, “Peroxisome proliferator-activated receptor γ coactivator 1α and FoxO3A mediate chondroprotection by AMP-activated protein kinase,” Arthritis and Rheumatology, vol. 66, no. 11, pp. 3073–3082, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. A. Hong, J. H. Lim, M. Y. Kim et al., “Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1α in db/db mice,” PLoS ONE, vol. 9, no. 5, Article ID e96147, 2014. View at Publisher · View at Google Scholar
  67. Y. Olmos, F. J. Sánchez-Gómez, B. Wild et al., “SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a/PGC-1α complex,” Antioxidants & Redox Signaling, vol. 19, no. 13, pp. 1507–1521, 2013. View at Publisher · View at Google Scholar
  68. Y. R. Chen, Y. L. Lai, S. D. Lin, X. T. Li, Y. C. Fu, and W. C. Xu, “SIRT1 interacts with metabolic transcriptional factors in the pancreas of insulin-resistant and calorie-restricted rats,” Molecular Biology Reports, vol. 40, no. 4, pp. 3373–3380, 2013. View at Publisher · View at Google Scholar
  69. S.-B. Wu, Y.-T. Wu, T.-P. Wu, and Y.-H. Wei, “Role of AMPK-mediated adaptive responses in human cells with mitochondrial dysfunction to oxidative stress,” Biochimica et Biophysica Acta—General Subjects, vol. 1840, no. 4, pp. 1331–1344, 2014. View at Publisher · View at Google Scholar
  70. M. Sandri, C. Sandri, A. Gilbert et al., “Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy,” Cell, vol. 117, no. 3, pp. 399–412, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Mammucari, G. Milan, V. Romanello et al., “FoxO3 controls autophagy in skeletal muscle in vivo,” Cell Metabolism, vol. 6, no. 6, pp. 458–471, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. S. E. Wohlgemuth, H. A. Lees, E. Marzetti et al., “An exploratory analysis of the effects of a weight loss plus exercise program on cellular quality control mechanisms in older overweight women,” Rejuvenation Research, vol. 14, no. 3, pp. 315–324, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. M. J. Drummond, O. Addison, L. Brunker et al., “Downregulation of E3 ubiquitin ligases and mitophagy-related genes in skeletal muscle of physically inactive, frail older women: a cross-sectional comparison,” Journals of Gerontology—Series A Biological Sciences and Medical Sciences, vol. 69, no. 8, pp. 1040–1048, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Sengupta, J. D. Molkentin, and K. E. Yutzey, “FoxO transcription factors promote autophagy in cardiomyocytes,” The Journal of Biological Chemistry, vol. 284, no. 41, pp. 28319–28331, 2009. View at Publisher · View at Google Scholar
  75. D. K. Kong, S. P. Georgescu, C. Cano et al., “Deficiency of the transcriptional regulator p8 results in increased autophagy and apoptosis, and causes impaired heart function,” Molecular Biology of the Cell, vol. 21, no. 8, pp. 1335–1349, 2010. View at Publisher · View at Google Scholar
  76. A. H. Chaanine, D. Jeong, L. Liang et al., “JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure,” Cell Death and Disease, vol. 3, no. 2, article e265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. D. J. Cao, N. Jiang, A. Blagg et al., “Mechanical unloading activates FoxO3 to trigger Bnip3-dependent cardiomyocyte atrophy,” Journal of the American Heart Association, vol. 2, no. 2, article e000016, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. K. E. van der Vos, P. Eliasson, T. Proikas-Cezanne et al., “Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy,” Nature Cell Biology, vol. 14, no. 8, pp. 829–837, 2012. View at Publisher · View at Google Scholar
  79. S. Kume, T. Uzu, K. Horiike et al., “Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney,” The Journal of Clinical Investigation, vol. 120, no. 4, pp. 1043–1055, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. H. Ni, A. Bhakta, S. Wang et al., “Role of hypoxia inducing factor-1β in alcohol-induced autophagy, steatosis and liver injury in mice,” PLoS ONE, vol. 9, no. 12, article e115849, 2014. View at Publisher · View at Google Scholar
  81. K. Fu, R. Hartlen, T. Johns, A. Genge, G. Karpati, and E. A. Shoubridge, “A novel heteroplasmic tRNAleu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy,” Human Molecular Genetics, vol. 5, no. 11, pp. 1835–1840, 1996. View at Publisher · View at Google Scholar
  82. M. Crimi, S. Galbiati, M. P. Perini et al., “A mitochondrial tRNAHis gene mutation causing pigmentary retinopathy and neurosensorial deafness,” Neurology, vol. 60, no. 7, pp. 1200–1203, 2003. View at Publisher · View at Google Scholar · View at Scopus
  83. N. Gutiérrez Cortés, C. Pertuiset, E. Dumon et al., “Novel mitochondrial DNA mutations responsible for maternally inherited nonsyndromic hearing loss,” Human Mutation, vol. 33, no. 4, pp. 681–689, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. I. Nelson, M. G. Hanna, N. Alsanjari, F. Scaravilli, J. A. Morgan-Hughes, and A. E. Harding, “A new mitochondrial DNA mutation associated with progressive dementia and chorea: a clinical, pathological, and molecular genetic study,” Annals of Neurology, vol. 37, no. 3, pp. 400–403, 1995. View at Publisher · View at Google Scholar · View at Scopus
  85. T. M. Young, E. L. Blakely, H. Swalwell et al., “Mitochondrial transfer RNA(Phe) mutation associated with a progressive neurodegenerative disorder characterized by psychiatric disturbance, dementia, and akinesia-rigidity,” Archives of Neurology, vol. 67, no. 11, pp. 1399–1402, 2010. View at Publisher · View at Google Scholar
  86. P. R. Smith, S. C. Bain, P. A. Good et al., “Pigmentary retinal dystrophy and the syndrome of maternally inherited diabetes and deafness caused by the mitochondrial DNA 3243 tRNA(Leu) A to G mutation,” Ophthalmology, vol. 106, no. 6, pp. 1101–1108, 1999. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Ogasahara, S. Yorifuji, Y. Nishikawa et al., “Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome,” Neurology, vol. 35, no. 3, pp. 372–377, 1985. View at Publisher · View at Google Scholar · View at Scopus
  88. C. M. Koehler, D. Leuenberger, S. Merchant, A. Renold, T. Junne, and G. Schatz, “Human deafness dystonia syndrome is a mitochondrial disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 5, pp. 2141–1246, 1999. View at Publisher · View at Google Scholar
  89. S. Hofmann, R. Bezold, M. Jaksch, P. Kaufhold, B. Obermaier-Kusser, and K.-D. Gerbitz, “Analysis of the mitochondrial DNA from patients with Wolfram (DIDMOAD) syndrome,” Molecular and Cellular Biochemistry, vol. 174, no. 1-2, pp. 209–213, 1997. View at Publisher · View at Google Scholar · View at Scopus
  90. O. Elpeleg, C. Miller, E. Hershkovitz et al., “Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion,” The American Journal of Human Genetics, vol. 76, no. 6, pp. 1081–1086, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Herlan, F. Vogel, C. Bornhövd, W. Neupert, and A. S. Reichert, “Processing of Mgm1 by the rhomboid-type protease Pcp1 is required for maintenance of mitochondrial morphology and of mitochondrial DNA,” Journal of Biological Chemistry, vol. 278, no. 30, pp. 27781–27788, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. R. Carrozzo, C. Dionisi-Vici, U. Steuerwald et al., “SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness,” Brain, vol. 130, no. 3, pp. 862–874, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. A. Roubertie, N. Leboucq, M. C. Picot et al., “Neuroradiological findings expand the phenotype of OPA1-related mitochondrial dysfunction,” Journal of the Neurological Sciences, vol. 349, no. 1-2, pp. 154–160, 2015. View at Publisher · View at Google Scholar · View at Scopus
  94. V. McCulloch, B. L. Seidel-Rogol, and G. S. Shadel, “A human mitochondrial transcription factor is related to RNA adenine methyltransferases and binds S-adenosylmethionine,” Molecular and Cellular Biology, vol. 22, no. 4, pp. 1116–1125, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. B. L. Seidel-Rogol, V. McCulloch, and G. S. Shadel, “Human mitochondrial transcription factor B1 methylates ribosomal RNA at a conserved stem-loop,” Nature Genetics, vol. 33, no. 1, pp. 23–24, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. N. Raimundo, L. Song, T. E. Shutt et al., “Mitochondrial stress engages E2F1 apoptotic signaling to cause deafness,” Cell, vol. 148, no. 4, pp. 716–726, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. H. C. Lee and Y. H. Wei, “Mitochondria and aging,” in Advances in Mitochondrial Medicine, vol. 942 of Advances in Experimental Medicine and Biology, pp. 311–327, Springer, Berlin, Germany, 2012. View at Publisher · View at Google Scholar
  98. G. A. Cortopassi and N. Arnheim, “Detection of a specific mitochondrial DNA deletion in tissues of older humans,” Nucleic Acids Research, vol. 18, no. 23, pp. 6927–6933, 1990. View at Publisher · View at Google Scholar
  99. A. Markaryan, E. G. Nelson, and R. Hinojosa, “Quantification of the mitochondrial DNA common deletion in presbycusis,” Laryngoscope, vol. 119, no. 6, pp. 1184–1189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Markaryan, E. G. Nelson, and R. Hinojosa, “Detection of mitochondrial DNA deletions in the cochlea and its structural elements from archival human temporal bone tissue,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 640, no. 1-2, pp. 38–45, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. N. Hoya, Y. Okamoto, K. Kamiya, M. Fujii, and T. Matsunaga, “A novel animal model of acute cochlear mitochondrial dysfunction,” NeuroReport, vol. 15, no. 10, pp. 1597–1600, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. Y. Okamoto, N. Hoya, K. Kamiya, M. Fujii, K. Ogawa, and T. Matsunaga, “Permanent threshold shift caused by acute cochlear mitochondrial dysfunction is primarily mediated by degeneration of the lateral wall of the cochlea,” Audiology & Neurotology, vol. 10, no. 4, pp. 220–233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. P. Evans and B. Halliwell, “Free radicals and hearing: cause, consequence, and criteria,” Annals of the New York Academy of Sciences, vol. 884, pp. 19–40, 1999. View at Publisher · View at Google Scholar · View at Scopus
  104. E. C. Bielefeld, B. H. Hu, K. C. Harris, and D. Henderson, “Damage and threshold shift resulting from cochlear exposure to paraquat-generated superoxide,” Hearing Research, vol. 207, no. 1-2, pp. 35–42, 2005. View at Publisher · View at Google Scholar
  105. M. B. Scher, A. Vaquero, and D. Reinberg, “SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress,” Genes & Development, vol. 21, no. 8, pp. 920–928, 2007. View at Publisher · View at Google Scholar
  106. D. B. Lombard, F. W. Alt, H.-L. Cheng et al., “Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation,” Molecular and Cellular Biology, vol. 27, no. 24, pp. 8807–8814, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. M. J. Rardin, J. C. Newman, J. M. Held et al., “Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 16, pp. 6601–6606, 2013. View at Publisher · View at Google Scholar · View at Scopus
  108. H.-S. Kim, K. Patel, K. Muldoon-Jacobs et al., “SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress,” Cancer Cell, vol. 17, no. 1, pp. 41–52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  109. K. Aquilano, P. Vigilanza, S. Baldelli, B. Pagliei, G. Rotilio, and M. R. Ciriolo, “Peroxisome proliferator-activated receptor γ co-activator 1 α (PGC-1α) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis,” The Journal of Biological Chemistry, vol. 285, no. 28, pp. 21590–21599, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. K. D. Brown, S. Maqsood, J.-Y. Huang et al., “Activation of SIRT3 by the NAD+ precursor nicotinamide riboside protects from noise-induced hearing loss,” Cell Metabolism, vol. 20, no. 6, pp. 1059–1068, 2014. View at Publisher · View at Google Scholar · View at Scopus
  111. J. Samson, A. Wiktorek-Smagur, P. Politanski et al., “Noise-induced time-dependent changes in oxidative stress in the mouse cochlea and attenuation by D-methionine,” Neuroscience, vol. 152, no. 1, pp. 146–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. R. D. Kopke, P. A. Weisskopf, J. L. Boone et al., “Reduction of noise-induced hearing loss using L-NAC and salicylate in the chinchilla,” Hearing Research, vol. 149, no. 1-2, pp. 138–146, 2000. View at Publisher · View at Google Scholar · View at Scopus
  113. Y.-M. Liu, X.-D. Li, X. Guo et al., “SOD2 V16A SNP in the mitochondrial targeting sequence is associated with noise induced hearing loss in Chinese workers,” Disease Markers, vol. 28, no. 3, pp. 137–147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  114. A. Konings, L. Van Laer, M. Pawelczyk et al., “Association between variations in CAT and noise-induced hearing loss in two independent noise-exposed populations,” Human Molecular Genetics, vol. 16, no. 15, pp. 1872–1883, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. G. Fortunato, E. Marciano, F. Zarrilli et al., “Paraoxonase and superoxide dismutase gene polymorphisms and noise-induced hearing loss,” Clinical Chemistry, vol. 50, no. 11, pp. 2012–2018, 2004. View at Publisher · View at Google Scholar · View at Scopus
  116. S. Ray and A. B. Reddy, “Cross-talk between circadian clocks, sleep-wake cycles, and metabolic networks: dispelling the darkness,” BioEssays, vol. 38, no. 4, pp. 394–405, 2016. View at Publisher · View at Google Scholar
  117. K.-F. Storch, O. Lipan, I. Leykin et al., “Extensive and divergent circadian gene expression in liver and heart,” Nature, vol. 417, no. 6884, pp. 78–83, 2002. View at Publisher · View at Google Scholar · View at Scopus
  118. D. P. King, M. H. Vitaterna, A.-M. Chang et al., “The mouse Clock mutation behaves as an antimorph and maps within the W(19H) deletion, distal of Kit,” Genetics, vol. 146, no. 3, pp. 1049–1060, 1997. View at Google Scholar · View at Scopus
  119. J. S. O'Neill and A. B. Reddy, “Circadian clocks in human red blood cells,” Nature, vol. 469, no. 7331, pp. 498–503, 2011. View at Publisher · View at Google Scholar
  120. C. B. Peek, A. H. Affinati, K. M. Ramsey et al., “Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice,” Science, vol. 342, no. 6158, Article ID 1243417, 2013. View at Publisher · View at Google Scholar · View at Scopus
  121. A. Neufeld-Cohen, M. S. Robles, R. Aviram et al., “Circadian control of oscillations in mitochondrial rate-limiting enzymes and nutrient utilization by PERIOD proteins,” Proceedings of the National Academy of Sciences, vol. 113, no. 12, pp. E1673–E1682, 2016. View at Publisher · View at Google Scholar
  122. A. Forge, “Outer hair cell loss and supporting cell expansion following chronic gentamicin treatment,” Hearing Research, vol. 19, no. 2, pp. 171–182, 1985. View at Publisher · View at Google Scholar · View at Scopus
  123. B. Kotecha and G. P. Richardson, “Ototoxicity in vitro: effects of neomycin, gentamicin, dihydrostreptomycin, amikacin, spectinomycin, neamine, spermine and poly-l-lysine,” Hearing Research, vol. 73, no. 2, pp. 173–184, 1994. View at Publisher · View at Google Scholar · View at Scopus
  124. W. Mckinney, A. Yonovitz, and M. H. Smolensky, “Circadian variation of gentamicin toxicity in rats,” Laryngoscope, vol. 125, no. 7, pp. E252–E256, 2015. View at Publisher · View at Google Scholar · View at Scopus
  125. I. Meltser, C. R. Cederroth, V. Basinou, S. Savelyev, G. S. Lundkvist, and B. Canlon, “TrkB-mediated protection against circadian sensitivity to noise trauma in the murine cochlea,” Current Biology, vol. 24, no. 6, pp. 658–663, 2014. View at Publisher · View at Google Scholar · View at Scopus
  126. I. Fariñas, K. R. Jones, L. Tessarollo et al., “Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression,” The Journal of Neuroscience, vol. 21, no. 16, pp. 6170–6180, 2001. View at Google Scholar · View at Scopus
  127. A. A. Dror and K. B. Avraham, “Hearing impairment: a panoply of genes and functions,” Neuron, vol. 68, no. 2, pp. 293–308, 2010. View at Publisher · View at Google Scholar